Da Volterra
🏢 View company profile →11Patents
10Active
11Granted
47Portfolio score
Filing activity: Aug 6, 2003 → Oct 24, 2018 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10052288B2 | Formulations for oral delivery of adsorbents in the gut | Human Necessities | 10 | Active |
| US8388984B2 | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules | Emerging Cross-Sectional Technologies | 9 | Active |
| US8273376B2 | Colonic delivery of metallo-dependent enzymes | Human Necessities | 5 | Active |
| US7485294B2 | Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof | Human Necessities | 5 | Expired |
| US8106000B2 | Colonic delivery of adsorbents | Human Necessities | 1 | Active |
| US7833765B2 | Galenic formulation for colon-targeted delivery of active ingredients | Human Necessities | 1 | Active |
| US9968562B2 | Formulations for oral delivery of adsorbents in the gut | Human Necessities | 1 | Active |
| US10982205B2 | Beta-lactamase variants | Human Necessities | 1 | Active |
| US10988749B2 | Beta-lactamase variants | Chemistry; Metallurgy | 1 | Active |
| US11365403B2 | Beta-lactamase variants | Human Necessities | 0 | Active |
| US11202761B2 | Formulations for oral delivery of adsorbents in the gut | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.